Purchase Order 75F40126P00174
- Not listed
- <p>The Department of Defense Medical Supply Chain issued a $2.92 million delivery order to Sanofi Vaccines US Inc. on February 20, 2026, for influenza virus vaccine procurement. The order is firm fixed price with an ultimate completion date of September 25, 2026. Place of performance is Swiftwater, PA 18370.</p>
- The U.S. government awarded a delivery order contract (No. 36E79726D0009) to Sanofi Vaccines US Inc., a division of Sanofi Pasteur Inc., for the procurement of influenza virus vaccine for the 2026-2027 season. This firm fixed-price contract, issued without set-aside designation, carries a ceiling value of $3,810.72 and was awarded on March 4, 2026, with an ultimate completion date of September 15, 2026. The contract will be performed at Sanofi Pasteur's facility in Swiftwater, Pennsylvania,...
- <p>The Department of Defense Medical Supply Chain issued a $3,178.20 delivery order to Sanofi Vaccines US Inc. on April 7, 2026, for influenza virus vaccine, with completion by April 24, 2026.</p> <p>Place of performance is Swiftwater, PA. The order is firm fixed price with no set-aside.</p>
- The U.S. General Services Administration awarded a firm fixed-price delivery order to Sanofi Vaccines US Inc. (a division of Sanofi Pasteur Inc.) for $1,793.28 on March 12, 2026, with an ultimate completion date of the same date. The contract covers the procurement of Sanofi Pasteur regular flu vaccine for fiscal year 2026 and was funded by the Federal Medical Center Rochester, a civilian federal agency. The place of performance is Swiftwater, Pennsylvania, where Sanofi Pasteur maintains its...
- The U.S. Department of Defense Medical Supply Chain awarded a $486,741.33 firm fixed-price delivery order to Sanofi Vaccines US Inc. (division of Sanofi Pasteur Inc.) on December 12, 2025, for the procurement of influenza virus vaccine. The contract, which carries no set-aside designation, is scheduled for completion by March 31, 2026, and will be performed at the contractor's facility in Swiftwater, Pennsylvania. Sanofi Pasteur Inc. is a foreign-owned pharmaceutical manufacturer and established...
- <p>The Defense Department's Medical Supply Chain issued a $11,282.61 delivery order to Sanofi Vaccines US Inc. on January 26, 2026, for influenza virus vaccine.</p> <p>Place of performance is Swiftwater, PA 18370. The order is firm fixed price with an ultimate completion date of March 31, 2026. No set-aside was used. The source does not identify the parent IDV or GWAC under which this delivery order was issued.</p>
- <p>The Department of Defense Medical Supply Chain issued a delivery order to Sanofi Vaccines US Inc. on February 20, 2026, with a ceiling value of $824,486 for influenza virus vaccine supply.</p> <p>Place of performance is Swiftwater, PA 18370. The order is firm fixed price with an ultimate completion date of September 25, 2026. No set-aside was used for this delivery order.</p>
- This is a firm fixed-price delivery order awarded by the Bureau of Administration, a civilian federal agency, to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of 2025-2026 flu vaccines. The contract has a ceiling value of $176,564.80 and a period of performance from September 9, 2025, to October 9, 2025. The contract is not set aside for any specific business category. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical...
- The U.S. government awarded a $1,457.04 firm fixed-price delivery order to Sanofi Vaccines US Inc. (operating under its division Sanofi Pasteur Inc.) on March 17, 2026, for the provision of staff influenza vaccines. The contract, designated as a mandatory national contract (36E79726D0009), is set to be completed by September 30, 2026, with performance taking place in Swiftwater, Pennsylvania. The Federal Medical Center Rochester, a civilian facility, serves as the funding agency for this vaccine...
- The U.S. Federal Medical Center Devens awarded a $3,642.60 firm fixed-price delivery order to Sanofi Vaccines US Inc. (operating division Sanofi Pasteur Inc.) on September 15, 2026, for the procurement of Fluzone pre-filled, single-dose syringes. The contract will support immunization efforts for both staff and inmate populations at the facility located in Swiftwater, Pennsylvania. No set-aside designation was applied to this award, and the contract completion date is September 15, 2026....
The Food and Drug Administration issued a purchase order to Sanofi Vaccines US Inc. on September 1, 2026, for seasonal influenza vaccine under the FDA Flu Vaccine Immunization Program with a firm fixed price of $28,095.80 and completion by November 1, 2026. The order procures 2,200 units of FDA-approved influenza vaccine for the 2026-2027 season: 2,000 units formulated for adults under 65 years of age and 200 units for adults 65 and older, delivered in single-dose pre-filled syringes compliant with CDC cold chain requirements. Place of performance is Swiftwater, Pennsylvania (Sanofi's primary U.S. manufacturing facility), with delivery to the FDA White Oak Campus in Silver Spring, Maryland and the FDA Jefferson Laboratories Campus in Jefferson, Arkansas. The originating solicitation, posted June 17, 2026 with quotations due July 20, 2026, evaluated proposals on lowest price technically acceptable basis, emphasizing delivery capability, regulatory approval confirmation, and packaging compliance with labeling requirements.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
FDA Flu Vaccine Immunization Program | 75F40126Q00257 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 6/17/26, 2:01 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.1k | 7/29/26 |